Blog

Qkine marks International Women’s Day 2026

Qkine are committed to supporting women across diverse career paths, hear from some of the amazing women that make our business.
Blog

Pep Talk February 2026

We've had a busy start to 2026 and share more exciting news for our cell therapy grade and new application notes, technotes and products.
Blog

BioLife solutions signs multi-year supply agreement with Qkine Limited to expand its product portfolio into the rapidly growing cytokines market

BioLife will distribute certain cytokine and growth factor products manufactured by Qkine for use in cell and gene therapy manufacturing
Blog

Andy

With a career that spans genetics, microbiology, antibodies, stem cells, and growth factors and a PhD earned alongside a full-time job, Andy’s journey is a testament to curiosity, adaptability, and quietly driving your own path. We caught up with Andy to talk about his career, the lessons that stuck, and why being brave enough to ask (even if the answer might be no) can make all the difference. 
Blog

Pep Talk January 2026

In our first newsletter of 2026 we share exciting news for our cell therapy grade and new application notes, technotes and products.
Blog

Commercially available media – the hidden pitfalls of proprietary formulations

Commercial media preparations can be a convenient option for stem cell and organoid maintenance and differentiation, but the proprietary 'black box' formulation prohibits trouble-shooting and optimization read our blog, as we ask, what's in it?
Blog

Raising the standard: Developing a high-quality IL-34 protein

Scientists have long struggled to access a reliable, animal-free, and high-quality version of IL-34. When we first started working on IL-34 at Qkine, we weren’t just trying to make another recombinant protein. We wanted to solve a real problem.
Blog

‍Qkine and Interlab announce distribution partnership in Taiwan

‍Qkine and Interlab based in Taipei, Taiwan, partner to distribute Qkine high purity growth factors and cytokines, empowering research in Taiwan.
Blog

Refined and benchmarked homemade media for cost-effective, weekend-free human pluripotent stem cell culture

In this recently revised and expanded paper from our collaborators in the Bertero lab, Truszkowski et al. have described a cost-effective homemade media recipe for the culture of human pluripotent stem cells (hPSCs), this adds to the evidence that homemade media using Qkine growth factors can be a suitable replacement for, or improvement on, commercially available media.
Blog

Laura

Laura’s role at Qkine may say Office Manager and QMS Assistant, but if you know her, you’ll know she’s so much more than that. She’s the kind of person who thrives on variety, always lends a helping hand, and keeps the engine room of Qkine running with precision, care, and an impressive number of color-coded email flags.
Blog

Why are Qkine’s new products labelled cell therapy grade and not GMP grade?

Why are the products labelled cell therapy grade and not GMP grade? Although GMP-grade is a recognized term within the growth factor space, it is not an accreditation that can be strictly applied to products outside of the pharmaceutical, cosmetic or food industries. 
Blog

Animal origin-free protein manufacture for cell therapy

Qkine cell therapy grade proteins are animal origin-free, but why is this so important? The FDA are clear in their recommendation that animal origin-free reagents are used for increased safety in cell and gene therapy manufacture.
Shopping Basket